Aquestive Therapeutics Market Cap

Aquestive Therapeutics has a market cap or net worth of $354.47 million as of April 25, 2024. Its market cap has increased by 388.26% in one year.

Market Cap

354.47M

Enterprise Value

439.57M

1-Year Change

388.26%

Ranking

#3227

Market Cap Chart

Since July 25, 2018, Aquestive Therapeutics's market cap has decreased from $385.20M to $354.47M, a decrease of -7.98%. That is a compound annual growth rate of -1.43%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	285.90M	-8.86%
Apr 23, 2024	313.70M	-2.30%
Apr 22, 2024	321.10M	6.71%
Apr 19, 2024	300.90M	-8.79%
Apr 18, 2024	329.90M	14.83%
Apr 17, 2024	287.30M	1.81%
Apr 16, 2024	282.20M	-2.29%
Apr 15, 2024	288.80M	0.77%
Apr 12, 2024	286.60M	-4.40%
Apr 11, 2024	299.80M	0.50%
Apr 10, 2024	298.30M	-0.50%
Apr 9, 2024	299.80M	0.50%
Apr 8, 2024	298.30M	-0.73%
Apr 5, 2024	300.50M	-1.44%
Apr 4, 2024	304.90M	-5.05%
Apr 3, 2024	321.10M	5.80%
Apr 2, 2024	303.50M	0.26%
Apr 1, 2024	302.70M	-3.07%
Mar 28, 2024	312.30M	3.93%
Mar 27, 2024	300.50M	0.97%
Mar 26, 2024	297.60M	-2.87%
Mar 25, 2024	306.40M	-4.58%
Mar 22, 2024	321.10M	-
Mar 21, 2024	321.10M	-2.76%
Mar 20, 2024	330.20M	-15.64%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Organogenesis Holdings	393.25M
Mereo BioPharma Group	389.36M
Biomea Fusion	388.70M
Mersana Therapeutics	387.07M
Tourmaline Bio	387.01M
Surmodics	383.23M
Revance Therapeutics	381.43M
PepGen	379.60M

Market Cap Rankings